Baxter Hlthcare Company Profile
What is the competitive landscape for BAXTER HLTHCARE
BAXTER HLTHCARE has two hundred and twenty-nine approved drugs.
There are thirty-two US patents protecting BAXTER HLTHCARE drugs. There are three tentative approvals on BAXTER HLTHCARE drugs.
Summary for Baxter Hlthcare
| US Patents: | 32 |
| Tradenames: | 311 |
| Ingredients: | 140 |
| NDAs: | 229 |
Drugs and US Patents for Baxter Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | heparin sodium | INJECTABLE;INJECTION | 018609-001 | Apr 28, 1982 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Baxter Hlthcare | IFEX/MESNEX KIT | ifosfamide; mesna | INJECTABLE;INJECTION | 019763-004 | Oct 10, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-003 | Nov 16, 2010 | RX | Yes | Yes | 9,200,088 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Baxter Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | IFEX | ifosfamide | INJECTABLE;INJECTION | 019763-001 | Dec 30, 1988 | 3,732,340 | ⤷ Start Trial |
| Baxter Hlthcare Corp | ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750-002 | Feb 24, 1998 | 6,207,661 | ⤷ Start Trial |
| Baxter Hlthcare | FORANE | isoflurane | LIQUID;INHALATION | 017624-001 | Approved Prior to Jan 1, 1982 | 3,535,388 | ⤷ Start Trial |
| Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-001 | Dec 24, 2008 | 5,134,127 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BAXTER HLTHCARE drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Inhalation | 99.90% | ➤ Subscribe | 2008-09-11 |
| ➤ Subscribe | Injection | 10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags | ➤ Subscribe | 2014-01-31 |
International Patents for Baxter Hlthcare Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2015508846 | ⤷ Start Trial |
| Japan | 2012072160 | ⤷ Start Trial |
| South Korea | 20110010742 | ⤷ Start Trial |
| Portugal | 3554474 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Baxter Hlthcare Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2203431 | CR 2015 00014 | Denmark | ⤷ Start Trial | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119 |
| 0748320 | 08C0019 | France | ⤷ Start Trial | PRODUCT NAME: FOSAPREPITANT DIMEGLUMINE; REGISTRATION NO/DATE: EU/1/07/437/001 20080111 |
| 0984957 | CR 2012 00035 | Denmark | ⤷ Start Trial | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
| 1189916 | 2011C/004 | Belgium | ⤷ Start Trial | PRODUCT NAME: REGADENOSON; AUTHORISATION NUMBER AND DATE: EU/1/10/643/001 20100906 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
